Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders

Agomelatine (AGM) is one of the latest atypical antidepressants, prescribed exclusively for the treatment of depression in adults. AGM belongs to the pharmaceutical class of melatonin agonist and selective serotonin antagonist (“MASS”), as it acts both as a selective agonist of melatonin receptors M...

Descripción completa

Detalles Bibliográficos
Autores principales: Savino, Rosa, Polito, Anna Nunzia, Marsala, Gabriella, Ventriglio, Antonio, Di Salvatore, Melanie, De Stefano, Maria Ida, Valenzano, Anna, Marinaccio, Luigi, Bellomo, Antonello, Cibelli, Giuseppe, Monda, Marcellino, Monda, Vincenzo, Messina, Antonietta, Polito, Rita, Carotenuto, Marco, Messina, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216109/
https://www.ncbi.nlm.nih.gov/pubmed/37239206
http://dx.doi.org/10.3390/brainsci13050734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216109/
https://www.ncbi.nlm.nih.gov/pubmed/37239206
http://dx.doi.org/10.3390/brainsci13050734

Ejemplares similares